Hence, our integrative bioinformatics and in vitro validation results suggest that the RB1 gene loss in retinoblastoma patients could provoke epigenetic events which in turn dysregulate the expression of E2F3 and thus promote Rb development in retinal cells. Here, E2F3 is linked to retinoblastoma.